UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 3.637

Sortiert nach

1.74 mΩcm2, High-Voltage 4H-SiC Vertical-Channel JFETs for High-Power Applications

2006 64th Device Research Conference, 2006, p.159-160

2006

Volltextzugriff (PDF)

1-Allyl-4-hydroxy-2,2-dioxo- N -(4-methoxyphenyl)-1 H -2λ 6 ,1-benzothiazine-3-carboxamide: polymorphic transition due to grinding with the loss of the biological activity

Acta crystallographica Section B, Structural science, crystal engineering and materials, 2022-02, Vol.78 (1), p.70-79

2022

Volltextzugriff (PDF)

1-Allyl-4-hydroxy-2,2-dioxo-N-(4-methoxyphenyl)-1H-2λ 6 ,1-benzothiazine-3-carboxamide: polymorphic transition due to grinding with the loss of the biological activity

Acta crystallographica Section B, Structural science, crystal engineering and materials, 2022-02, Vol.78 (Pt 1), p.70

2022

Volltextzugriff (PDF)

1‐Allyl‐4‐hydroxy‐2,2‐dioxo‐N‐(4‐methoxyphenyl)‐1H‐2λ6,1‐benzothiazine‐3‐carboxamide: polymorphic transition due to grinding with the loss of the biological activity

Acta crystallographica Section B, Structural science, crystal engineering and materials, 2022-02, Vol.78 (1), p.70-79

2022

Volltextzugriff (PDF)

1089P - Invasive fungal diseases in patients with Hodgkin’s lymphoma before and after allogeneic hematopoietic stem cell transplantation

Annals of oncology, 2019-10, Vol.30, p.v442-v442

2019

Volltextzugriff (PDF)

1089PInvasive fungal diseases in patients with Hodgkin’s lymphoma before and after allogeneic hematopoietic stem cell transplantation

Annals of oncology, 2019-10, Vol.30 (Supplement_5)

2019

Volltextzugriff (PDF)

108TiPEMPOWER-lung 1: A randomized, open-label, multi-national, phase III trial of cemiplimab, a human PD-1 monoclonal antibody, versus chemotherapy in first-line treatment of advanced non-small cell lung cancer (NSCLC) with PD-L1 ≥50

Annals of oncology, 2018-12, Vol.29 (suppl_10)

2018

Volltextzugriff (PDF)

1090P - Invasive fungal diseases caused by rare pathogens in patients after hematopoietic stem cell transplantation (HSCT) & chemotherapy

Annals of oncology, 2019-10, Vol.30, p.v442-v442

2019

Volltextzugriff (PDF)

1090PInvasive fungal diseases caused by rare pathogens in patients after hematopoietic stem cell transplantation (HSCT) & chemotherapy

Annals of oncology, 2019-10, Vol.30 (Supplement_5)

2019

Volltextzugriff (PDF)

(110) face reconstruction of small single crystal gold particles

Journal of crystal growth, 1985-05, Vol.71 (3), p.735-738

1985

Volltextzugriff (PDF)

141O Durvalumab (D) ± tremelimumab (T) + platinum-etoposide (EP) in 1L extensive-stage (ES) SCLC: Characteristics of long-term survivors in the CASPIAN study

Annals of oncology, 2022-04, Vol.33, p.S97-S98

2022

Volltextzugriff (PDF)

1530P Durvalumab (D) + platinum-etoposide (EP) in first-line extensive-stage SCLC (ES SCLC): Effect of age and platinum agent on outcomes in CASPIAN

Annals of oncology, 2022-09, Vol.33, p.S1245-S1246

2022

Volltextzugriff (PDF)

1565PA phase III study comparing SB8, a proposed bevacizumab biosimilar, and reference bevacizumab in patients with metastatic or recurrent non-squamous NSCLC

Annals of oncology, 2019-10, Vol.30 (Supplement_5)

2019

Volltextzugriff (PDF)

160 m Pulsations in the magnetosphere of the Earth possibly caused by oscillations of the Sun

Solar physics, 1983-01, Vol.82 (1-2), p.451-455

1983

Volltextzugriff (PDF)

1665PDPreliminary efficacy of durvalumab plus tremelimumab in platinum-refractory/resistant ED-SCLC from arm A of the phase II BALTIC study

Annals of oncology, 2018-10, Vol.29 (suppl_8)

2018

Volltextzugriff (PDF)

1866 First results from the double-blind placebo (PL)-controlled randomised phase III MERiDiAN trial prospectively evaluating plasma (p)VEGF-A in patients (pts) receiving first-line paclitaxel (PAC) +/- bevacizumab (BV) for HER2-negative metastatic breast cancer (mBC)

European journal of cancer (1990), 2015-09, Vol.51, p.S287-S288

2015

Volltextzugriff (PDF)

1S-2S energy shift in muonic hydrogen

EPJ Web of Conferences, 2019, Vol.204, p.5005

2019

Volltextzugriff (PDF)

2,3,4,5-Tetraiodopyrrole as a building block for halogen bonding: Formation of supramolecular hybrids with organic iodide salts in solid state

Journal of molecular structure, 2021-04, Vol.1230, p.129931, Article 129931

2021

Volltextzugriff (PDF)

2-isoxazolines from arylcyclopropanes: I. Monoarylcyclopropanes in a reaction with nitrosyl chloride activated by sulfur(IV) oxide

Russian journal of organic chemistry, 2006-02, Vol.42 (2), p.249-255

2006

Volltextzugriff (PDF)

2-Isoxazolines from Arylcyclopropanes. Part 1. Monoarylcyclopropanes in a Reaction with Nitrosyl Chloride Activated by Sulfur(IV) Oxide

ChemInform, 2006-07, Vol.37 (29), p.no-no

2006

Volltextzugriff (PDF)

2-METHYLPYRIDINIUM SALT OF PENTAIODOBENZOIC ACID: ROLE OF THE HALOGEN BOND IN THE FORMATION OF A CRYSTAL PACKING

Journal of structural chemistry, 2021-08, Vol.62 (8), p.1237-1242

2021

Volltextzugriff (PDF)

(252)Cf-plasma desorption mass spectra of bacterial oligosaccharides

Bioorganicheskaia khimiia, 1994-07, Vol.20 (7), p.782

1994

Volltextzugriff (PDF)

268 - Incidence and risk factors for venous thromboembolism after transurethral resection of bladder tumor: A population-based analysis

European urology supplements : official journal of the European Association of Urology, 2017-03, Vol.16 (3), p.e468-e469

2017

Volltextzugriff (PDF)

1 – 25 von 3.637

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(3.020)
Mit Volltextzugriff
(2.816)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

4 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(1.481)
Physical Sciences
(842)
Humans
(578)
Technology
(501)
Chemistry
(500)
Physics
(438)
Life Sciences & Biomedicine
(361)
Chemistry And Materials Science
(343)
Male
(326)
Materials Science
(278)
Female
(261)
Animals
(257)
Adult
(234)
Engineering
(184)
Middle Aged
(180)
Materials Science, Multidisciplinary
(156)
Chemistry, Physical
(132)
Chemistry, Multidisciplinary
(120)
Adolescent
(116)
Physics, Applied
(115)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

1.74 mΩcm2, High-Voltage 4H-SiC Vertical-Channel JFETs for High-Power Applications

1-Allyl-4-hydroxy-2,2-dioxo- N -(4-methoxyphenyl)-1 H -2λ 6 ,1-benzothiazine-3-carboxamide: polymorphic transition due to grinding with the loss of the biological activity

1-Allyl-4-hydroxy-2,2-dioxo-N-(4-methoxyphenyl)-1H-2λ 6 ,1-benzothiazine-3-carboxamide: polymorphic transition due to grinding with the loss of the biological activity

1‐Allyl‐4‐hydroxy‐2,2‐dioxo‐N‐(4‐methoxyphenyl)‐1H‐2λ6,1‐benzothiazine‐3‐carboxamide: polymorphic transition due to grinding with the loss of the biological activity

1089P - Invasive fungal diseases in patients with Hodgkin’s lymphoma before and after allogeneic hematopoietic stem cell transplantation

1089PInvasive fungal diseases in patients with Hodgkin’s lymphoma before and after allogeneic hematopoietic stem cell transplantation

108TiPEMPOWER-lung 1: A randomized, open-label, multi-national, phase III trial of cemiplimab, a human PD-1 monoclonal antibody, versus chemotherapy in first-line treatment of advanced non-small cell lung cancer (NSCLC) with PD-L1 ≥50

1090P - Invasive fungal diseases caused by rare pathogens in patients after hematopoietic stem cell transplantation (HSCT) & chemotherapy

1090PInvasive fungal diseases caused by rare pathogens in patients after hematopoietic stem cell transplantation (HSCT) & chemotherapy

(110) face reconstruction of small single crystal gold particles

141O Durvalumab (D) ± tremelimumab (T) + platinum-etoposide (EP) in 1L extensive-stage (ES) SCLC: Characteristics of long-term survivors in the CASPIAN study

1530P Durvalumab (D) + platinum-etoposide (EP) in first-line extensive-stage SCLC (ES SCLC): Effect of age and platinum agent on outcomes in CASPIAN

1565PA phase III study comparing SB8, a proposed bevacizumab biosimilar, and reference bevacizumab in patients with metastatic or recurrent non-squamous NSCLC

160 m Pulsations in the magnetosphere of the Earth possibly caused by oscillations of the Sun

1665PDPreliminary efficacy of durvalumab plus tremelimumab in platinum-refractory/resistant ED-SCLC from arm A of the phase II BALTIC study

1866 First results from the double-blind placebo (PL)-controlled randomised phase III MERiDiAN trial prospectively evaluating plasma (p)VEGF-A in patients (pts) receiving first-line paclitaxel (PAC) +/- bevacizumab (BV) for HER2-negative metastatic breast cancer (mBC)

1S-2S energy shift in muonic hydrogen

2,3,4,5-Tetraiodopyrrole as a building block for halogen bonding: Formation of supramolecular hybrids with organic iodide salts in solid state

2-isoxazolines from arylcyclopropanes: I. Monoarylcyclopropanes in a reaction with nitrosyl chloride activated by sulfur(IV) oxide

2-Isoxazolines from Arylcyclopropanes. Part 1. Monoarylcyclopropanes in a Reaction with Nitrosyl Chloride Activated by Sulfur(IV) Oxide

2-METHYLPYRIDINIUM SALT OF PENTAIODOBENZOIC ACID: ROLE OF THE HALOGEN BOND IN THE FORMATION OF A CRYSTAL PACKING

220O Claudin 18.2 - a novel treatment target in the multicenter, randomized, phase II FAST study, a trial of epirubicin, oxaliplatin, and capecitabine (EOX) with or without the anti-CLDN18.2 antibody IMAB362 as 1st line therapy in advanced gastric and gastroesophageal junction (GEJ) cancer

220O Claudin 18.2 – a novel treatment target in the multicenter, randomized, phase II FAST study, a trial of epirubicin, oxaliplatin, and capecitabine (EOX) with or without the anti-CLDN18.2 antibody IMAB362 as 1st line therapy in advanced gastric and gastroesophageal junction (GEJ) cancer

(252)Cf-plasma desorption mass spectra of bacterial oligosaccharides

268 - Incidence and risk factors for venous thromboembolism after transurethral resection of bladder tumor: A population-based analysis

Suchergebnisse filtern